Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $223.4950 (0.43%) ($223.4950 - $223.4950) on Fri. Sep. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.54% (three month average) | RSI | 49 | Latest Price | $223.4950(0.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | UTHR declines -0.2% a day on average for past five trading days. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(37%) VYM(29%) XBI(26%) XLP(25%) XLU(25%) | Factors Impacting UTHR price | UTHR will decline at least -0.77% in a week (0% probabilities). VXX(-17%) VIXM(-14%) UUP(-9%) TBT(-4%) BND(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.77% (StdDev 1.54%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $222.74(0.34%) | 10 Day Moving Average | $222(0.67%) | 20 Day Moving Average | $221.85(0.74%) | To recent high | -8.4% | To recent low | 3.8% | Market Cap | $9.914b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |